Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter]

Affiliations

• ¹ University of Toronto, Toronto, ON, Canada. david.cherney@uhn.ca.
• ² University of Nantes, Nantes, France.
• ³ Unit of Cardiology, Karolinska Institute & Karolinska University Hospital, Stockholm, Sweden.
• ⁴ University of Tennessee Health Science Center, Memphis, TN, USA.
• ⁵ University of Texas Southwestern Medical Center, Dallas, TX, USA.
• ⁶ Parkland Health and Hospital System, Dallas, TX, USA.
• ⁷ AdventHealth Translational Research Institute, Orlando, FL, USA.
• ⁸ Rutgers School of Public Health, New Brunswick, NJ, USA.
• ⁹ Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
• ¹⁰ Pfizer Inc., Collegeville, PA, USA.
• ¹¹ MSD Limited, London, UK.
• ¹² Merck & Co., Inc., Kenilworth, NJ, USA.
• ¹³ Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.